GIOMMONI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 2.167
NA - Nord America 2.109
AS - Asia 1.523
SA - Sud America 129
AF - Africa 37
OC - Oceania 20
Totale 5.985
Nazione #
US - Stati Uniti d'America 2.063
RU - Federazione Russa 582
PL - Polonia 577
IT - Italia 458
CN - Cina 452
SG - Singapore 399
HK - Hong Kong 190
IE - Irlanda 142
VN - Vietnam 139
KR - Corea 128
BR - Brasile 102
FI - Finlandia 70
IN - India 65
SE - Svezia 64
FR - Francia 60
DE - Germania 57
AT - Austria 40
JO - Giordania 38
ID - Indonesia 34
GB - Regno Unito 32
NL - Olanda 25
CA - Canada 23
AU - Australia 20
CH - Svizzera 20
JP - Giappone 20
MX - Messico 18
BD - Bangladesh 15
ES - Italia 10
ZA - Sudafrica 10
IQ - Iraq 9
AR - Argentina 8
MA - Marocco 7
UA - Ucraina 7
NG - Nigeria 6
PK - Pakistan 6
VE - Venezuela 6
CZ - Repubblica Ceca 4
EG - Egitto 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BE - Belgio 3
CL - Cile 3
EC - Ecuador 3
LT - Lituania 3
TR - Turchia 3
CI - Costa d'Avorio 2
CO - Colombia 2
ET - Etiopia 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 5.985
Città #
Warsaw 576
Santa Clara 509
Ashburn 370
Singapore 273
Hong Kong 170
Hefei 151
Dublin 136
Seoul 128
San Jose 111
Florence 92
Fairfield 88
Chandler 63
Council Bluffs 62
Beijing 54
Seattle 45
Los Angeles 44
Helsinki 40
Vienna 39
Woodbridge 37
Ho Chi Minh City 36
Milan 35
Wilmington 35
Cambridge 34
Munich 34
New York 33
Houston 32
Lauterbourg 32
Dallas 31
Jakarta 31
Buffalo 29
Hanoi 29
Moscow 29
Boston 24
Paris 24
Rome 23
Lawrence 22
Shanghai 22
Altamura 21
Pune 20
Boardman 19
Kent 19
Mumbai 19
Melbourne 18
Bern 16
Dong Ket 16
The Dalles 16
Tokyo 16
Turku 16
Princeton 15
London 12
Bengaluru 11
São Paulo 11
Ann Arbor 8
Brescia 8
Lappeenranta 8
Montesilvano Marina 8
Toronto 8
West Jordan 8
Amsterdam 7
Atlanta 7
Frankfurt am Main 7
Johannesburg 7
Medford 7
Montreal 7
Orem 7
Phoenix 7
Bremen 6
Dearborn 6
Haiphong 6
Redondo Beach 6
San Diego 6
Shenzhen 6
Tianjin 6
Abuja 5
Belo Horizonte 5
Brasília 5
Charlotte 5
Chicago 5
Cinisello Balsamo 5
Genoa 5
Mexico City 5
Amandola 4
Barnet 4
Biên Hòa 4
Brooklyn 4
Chennai 4
Clifton 4
Falls Church 4
Hangzhou 4
Hillsboro 4
Hải Dương 4
Karachi 4
Naples 4
Siena 4
Tashkent 4
Turin 4
Yokohama 4
Yubileyny 4
Alba 3
Amman 3
Totale 4.028
Nome #
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: A phase II study 342
hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications 333
VEGF-A clinical significance in gastric cancers: immunohistochemical analysis of a wide Italian cohort. 293
Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification 267
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 246
HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research 235
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 223
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 219
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 197
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 195
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 193
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 193
Update on gastric cancer treatments and gene therapies 189
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 185
Somatostatin analogs in pregnant patients with neuroendocrine tumor 182
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 178
Systemic Sclerosis Association with Malignancy 176
Results of the observational prospective RealFLOT study 175
Immune-related adverse events in oncological patients treated with immune checkpoint inhibitors 175
hERG1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study. 170
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 169
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 164
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors 163
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study) 154
Editorial: Redox Potential and Metabolic Behavior in Gastrointestinal Cancers 153
Regorafenib also can cause osteonecrosis of the jaw 144
Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients 143
Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine 126
Response 123
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 118
Treatment Strategy for Oligometastatic Gastric Cancer: Brief Considerations 91
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 69
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT) 35
Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift 33
Totale 6.051
Categoria #
all - tutte 18.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 0 7 19
2021/2022114 2 2 5 3 4 1 4 17 11 8 26 31
2022/2023490 23 70 17 24 36 97 67 40 61 14 19 22
2023/2024445 8 29 33 17 30 73 26 80 11 42 46 50
2024/20251.828 48 161 103 271 456 253 41 115 80 59 105 136
2025/20262.237 300 325 278 226 255 74 258 127 153 158 83 0
Totale 6.051